Johnson & Johnson stock slipped Tuesday after the company reported first-quarter earnings that surpassed expectations and boosted its full-year sales forecast. The pharmaceutical and biotech giant ...

The company continues to face litigation over its talc baby powder, taken off the market in 2023. Netflix Aims to Join the $1 Trillion Club The streaming service has shared financial performance ...

With recession concerns circulating in the market, Johnson & Johnson (JNJ) stock could stabilize many portfolios. Since its founding in ...